GH Research (GHRS) Receivables - Other (2023 - 2025)

GH Research (GHRS) recorded quarterly Receivables - Other of $1.2 million in Q4 2025, down 26.8% quarter-over-quarter from $1.6 million in Q4 2024, and down 26.8% on a YoY basis from $1.6 million in Q4 2024.

GH Research (GHRS) Receivables - Other (2023 - 2025) Analysis & Trends

GH Research's Receivables - Other history runs 3 years deep, the most recent figure standing at $1.2 million for Q4 2025.

  • In Q4 2025, Receivables - Other fell 26.8% year-over-year to $1.2 million; the TTM figure through Dec 2025 stood at $1.2 million (down 26.8% YoY), while the FY2025 annual figure was $1.2 million, down 26.8% from the prior year.
  • Receivables - Other was $1.2 million for Q4 2025 at GH Research, down from $1.6 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $1.6 million in Q4 2024 to a low of $119000.0 in Q4 2023.
  • Historically, Receivables - Other has averaged $953000.0 across 3 years, with a median of $1.2 million in 2025.
  • The sharpest annual moves came in 2024 and 2025: Receivables - Other jumped 1229.41% in 2024, then retreated 26.8% in 2025.
  • A 3-year view of Receivables - Other shows it stood at $119000.0 in 2023, then surged by 1229.41% to $1.6 million in 2024, then retreated by 26.8% to $1.2 million in 2025.
  • The last three Receivables - Other figures came in at $1.2 million (Q4 2025), $1.6 million (Q4 2024), and $119000.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 GH Research 9.73 Bn 9.63 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.16 Mn
Dec 31, 2025 1.16 Mn
Dec 31, 2024 1.58 Mn
Dec 31, 2024 1.58 Mn
Dec 31, 2023 119,000.00
Dec 31, 2023 119,000.00